Natural-gas producer EQT drills for gas primarily in Pennsylvania, West Virginia and Ohio, utilizing the practice of “fracking” to extract gas from shale deposits.  EQT sought to acquire a rival company, Rice by way of a merger (the “Rice Acquisition” or “Acquisition”). Rice held various tracts of lands adjacent to EQT’s property.  The Rice Acquisition, announced on June 19,  2017,  would  expand  the  total  acreage  available  for  EQT’s  drilling  and  fracking.

RLX Technology Inc. manufactures and sells vaping products in China.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute pain. The Company’s lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-tosevere acute pain. DSUVIA is a potent opioid painkiller that is of particular use in certain special circumstances where adult patients may not be able to swallow oral medication and where access to intravenous pain relief is not possible.

Frequency Therapeutics, Inc. is primarily focused on the development and commercialization of a hearing loss treatment called “FX-322.”

Virgin Galactic Holdings, Inc. is an integrated aerospace company that develops human spaceflight for private individuals and researchers in the U.S.

Nutanix, Inc. purports to be a cloud computing software company headquartered in San Jose, California known for pioneering its “core” hyper-converged infrastructure (“HCI”) software technology, which combines the components of data center computing (server, storage, and virtualization) into a single scalable machine through software.

Houston Wire & Cable Company is a large provider of wire and cable and fastener products in the U.S. market.

Nuance Communications, Inc. is a pioneer and a leading provider of conversational AI and cloud-based ambient clinical intelligence for healthcare providers. Nuance’s products include the Dragon Ambient eXperience, Dragon Medical One and PowerScribe One for radiology reporting, all leading clinical speech recognition SaaS offerings built on Microsoft Azure.

GW Pharmaceuticals, PLC is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from their proprietary cannabinoid product platform in a broad range of disease areas. GW commercialized the world’s first plant-derived cannabinoid prescription drug, Sativex, which is approved for the treatment of spasticity due to multiple sclerosis in 25 countries. The Company has two primary, more developed products: Epidiolex and Nabiximols (Sativex). GW also has a deep pipeline of additional cannabinoid product candidates and novel compounds, including compounds in Phase 1, Phase 2, and Phase 3 trials.

PRA Health Sciences, Inc. is one of the world’s leading global contract research organizations (“CRO”).

Washington Prime Group, Inc. is a self-managed and self-administered real estate investment trust (“REIT”) that owns properties and conducts operations through Washington Prime Group, L.P.

Provention Bio, Inc. is a clinical stage biopharmaceutical company that focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. The Company’s product candidates include, among others, PRV-031 teplizumab and mAb, in Phase III clinical trial for the interception of T1D.

Ubiquiti Inc. develops and markets equipment and technology platforms for high capacity Internet access, unified information technology, and consumer electronics.

ContextLogic Inc. is a San Francisco-based, global mobile ecommerce company that operates the Wish platform that connects its value-conscious user base to merchants. Founded in 2010, Wish is a global e-commerce platform that generates revenue by charging merchants a commission on sales made in its marketplace. The Company also generates fees by offering advertising and logistics services to its merchants. With a large range of beauty, clothing and electronics products sold at wholesale prices, Wish claims to have managed to swiftly garner a user base of 100 million monthly active users and 500,000 merchants.

Array Technologies, Inc. describes itself as one of the world’s largest manufacturers of groundmounting systems used in solar energy projects. The Company's principal products are commonly referred to as "trackers." Trackers are designed to move solar panels throughout the day to maintain an optimal orientation to the sun, which significantly increases their energy production.

Danimer Scientific, Inc. was formerly known as “Live Oak Acquisition Corp.,” a publicly traded SPAC. In December 2020, Live Oak consummated the Business Combination with Legacy Danimer, a performance polymer company specializing in bioplastic replacements for traditional petrochemical-based plastics. Following the Business Combination, Live Oak changed its name to “Danimer Scientific, Inc.,” changed its business to Legacy Danimer’s business, and replaced its management with Legacy Danimer’s management.

Aterian, Inc. purports to be a “technology enabled consumer products platform that builds, acquires and partners with e-commerce brands. The Company’s proprietary software and highly agile supply chain helps creating for a growing base of data empowered e-commerce customers. Aterian predominantly operates through online retail channels such as Amazon and Walmart, Inc."

Purecycle Technologies, Inc. purports to commercialize a purification recycling technology, originally developed by The Procter & Gamble Company, for restoring waste polypropylene into resin with near-virgin characteristics.

On November 16, 2020, PureCycle issued a press release announcing plans to become a publicly traded company via a merger with Roth CH Acquisition I Co ("Roth Acquisition"). Roth Acquisition was set up as a special purpose acquisition company (commonly referred to as a SPAC). Roth Acquisition’s shares traded on the NASDAQ stock exchange under the ticker symbol “ROCH.”

Skillz Inc. (f/k/a Flying Eagle Acquisition Corp or "FEAC") operates an online mobile multiplayer competition proprietary platform. Players use it to compete in online competitions against other players across the world. FEAC was formed as a SPAC in early January 2020 by its sponsor Eagle Equity Partners II, LLC.

ChemoCentryx is a biopharmaceutical company focused on the development and commercialization of new medications targeting inflammatory disorders, autoimmune diseases, and cancer. The Company commenced operations in 1997. ChemoCentryx’s lead drug candidate is avacopan, which the Company describes as “a potential first-in-class, orally-administered molecule that employs a novel for the treatment of patients with ANCA vasculitis.